Q3 2025 Healthequity Inc Earnings Call Transcript

Dec 09, 2024 / 09:30PM GMT

Key Points

Positve
  • HealthEquity Inc (HQY) reported double-digit year-over-year growth in key metrics, including a 21% increase in revenue and a 24% rise in adjusted EBITDA.
  • The company ended Q3 with 16.5 million total accounts, including 9.5 million HSAs, and HSA assets increased by $7.4 billion year over year.
  • HSA members grew by 15%, driving total accounts up by 8%, and the number of HSA members who invest increased by 21%, boosting invested assets by 58% to $13.6 billion.
  • HealthEquity Inc (HQY) raised its FY25 guidance and provided an initial FY26 outlook, expecting revenue growth and margin expansion.
  • The company successfully completed the final wave of single card processor consolidation and is leveraging AI to enhance member experiences and reduce service costs.
Negative
  • HealthEquity Inc (HQY) faced $8 million in excess service costs due to sophisticated fraud activity and the final phase of card processor consolidation.
  • The company anticipates a challenging year-over-year new HSA sales comparison in Q4 due to a strong performance in the previous year.
  • There is potential for healthy churn in CDB products due to incremental price increases, which could impact retention.
  • The fiscal 2026 revenue guidance reflects high single-digit growth, which may be below consensus expectations.
  • The commuter offering remains stable at 60-65% of pre-pandemic levels, indicating slow recovery in this segment.
Operator

Good afternoon and welcome to the HealthEquity third-quarter 2025 earnings conference call. Please note, this event is being recorded. I would now like to turn the conference over to Richard Putnam. Please go ahead.

Richard Putnam
Healthequity Inc - Investor Relations

Thank you, Nick. Hello, everyone. Welcome to HealthEquity's third-quarter of fiscal year 2025 earnings conference call. My name is Richard Putnam, Investor Relations for HealthEquity. And joining me today is Jon Kessler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founder of the company; James Lucania, Executive Vice President and CFO; Scott Cutler, recently appointed successor President and CEO beginning in January.

Before I turn the call over to Jon, I have a couple of reminders. First, a press release announcing the financial results for our third quarter of fiscal 2025 was issued after the market closed this afternoon. These financial results include the contributions of our wholly owned subsidiaries and accounts they administer. Press release includes definitions of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot